Anticoagulation for Elderly Patients Post Ankle Fracture Surgery with Renal Impairment

Primary Recommendation: Aspirin-Based Thromboprophylaxis

• The American Geriatrics Society recommends reducing enoxaparin to 30 mg subcutaneously once daily for prophylaxis in patients with severe renal impairment (CrCl <30 mL/min) 1, 2
• The American College of Cardiology suggests that patients with CrCl <30 mL/min have 2.25 times higher odds of major bleeding (OR 2.25, 95% CI 1.19-4.27) without dose adjustment 1, 3

Dosing Algorithm for Enoxaparin

• The National Comprehensive Cancer Network recommends reducing prophylactic dose by 25% (consider 30 mg once daily instead of 40 mg) for moderate renal impairment (CrCl 30-50 mL/min) 1, 2
• Enoxaparin clearance decreases by 31% in moderate renal impairment 2

Monitoring Requirements for Enoxaparin

• The American College of Cardiology recommends monitoring anti-Xa levels in all patients with severe renal impairment 1, 2
• The target prophylactic anti-Xa range is 0.29-0.34 IU/mL 1

Alternative Anticoagulation Strategy: Unfractionated Heparin

• The Journal of the American Geriatrics Society recommends dosing unfractionated heparin at 5000 IU subcutaneously twice daily for prophylaxis in severe renal impairment (CrCl <30 mL/min) 4
• Unfractionated heparin undergoes reticuloendothelial clearance, not renal, eliminating accumulation risk 1, 2

Contraindicated Agents

• The National Comprehensive Cancer Network states that fondaparinux is absolutely contraindicated when CrCl <30 mL/min 5, 1, 2
• Fondaparinux has a very long half-life (17-21 hours) with renal elimination, making accumulation inevitable 5

Special Consideration: Warfarin Bridging

• The American Geriatrics Society recommends initiating warfarin at <5 mg daily in older people due to increased pharmacodynamic response 6, 4
• The American College of Cardiology suggests continuing heparin/enoxaparin until INR therapeutic for >48 hours 6, 4